Experience. Commitment. Results.
Vigil Neuroscience, Inc. (NASDAQ: VIGL), relating to the proposed Merger with Sanofi (SASY.PA), pursuant to which Sanofi will acquire Vigil for an upfront payment of $8.00 per share of common stock in cash. Vigil shareholders will also receive a non-tradeable contingent value right entitling the holder to potentially receive an additional $2.00 per share in cash payable … Read more
Star Equity Holdings, Inc. (NASDAQ: STRR), relating to the proposed Merger with Hudson Globl, Inc. that will create NewCo. Upon completion of the Merger, Hudson shareholders will own approximately 79% of NewCo, and Star shareholders will own approximately 21% of NewCo’s estimated 3.49 million shares outstanding. Pending regulatory and shareholder approvals, the proposed Merger is anticipated … Read more
SigmaTron International, Inc. (NASDAQ: SGMA), relating to the proposed merger with Transom Capital Group, LLC. Under the terms of the agreement, an affiliate of Transom will commence a tender offer to acquire all outstanding shares of the Company’s common stock for $3.02 per share in cash.
CFSB Bancorp, Inc. (NASDAQ: CFSB), relating to the proposed merger with Hometown Financial Group, Inc. Under the terms of the agreement, CFSB shareholders will receive $14.25 in cash for each share of CFSB common stock.
TXNM Energy (NYSE: TXNM), relating to the proposed merger with Blackstone Infrastructure. Under the terms of the agreement, Blackstone Infrastructure will acquire TXNM Energy for $61.25 per share in cash.
Protagenic Therapeutics, Inc. (NASDAQ: PTIX), relating to the proposed merger with Phytanix Bio Inc. Under the terms of the agreement, stockholders of Protagenic Therapeutics will own approximately 35% of the combined company.
Servotronics, Inc. (NYSE: SVT), relating to the proposed merger with TransDigm Group Incorporated. Under the terms of the agreement, a subsidiary of TransDigm will commence a tender offer to acquire all the outstanding shares of Servotronics for $38.50 per share in cash.
Charter Communications, Inc. (NASDAQ: CHTR), relating to the proposed merger with Cox Communications. Under the terms of the agreement, Cox Enterprises will own approximately 23% of the combined entity’s fully diluted shares outstanding.
Inozyme Pharma, Inc. (NASDAQ: INZY), relating to the proposed merger with BioMarin Pharmaceutical Inc. Under the terms of the agreement, BioMarin will commence a cash tender offer to acquire all of the outstanding shares of Inozyme common stock at a price of $4.00 per share.
Foot Locker, Inc. (NYSE: FL), relating to the proposed merger with DICK’S Sporting Goods, Inc. Under the terms of the agreement, Foot Locker shareholders will elect to receive either $24.00 in cash or 0.1168 shares of DICK’S common stock for each share of Foot Locker common stock.